Abiraterone
Commons · Question 46588 · Tabled 17 Apr 2025 · Department of Health and Social Care · Official record
Answered 29 Apr 2025
Question
Asked by Edward Morello
To ask the Secretary of State for Health and Social Care, whether he has had discussions with his counterparts in (a) Scotland, (b) Wales and (c) Northern Ireland on equitable access to abiraterone acetate for high-risk, non-metastatic prostate cancer pat
Answer
Answered by Karin Smyth, 29 Apr 2025
Decisions on the availability of medicines in Scotland, Wales, and Northern Ireland are a matter for the devolved administrations.